ARTICLE | Company News
Vertex deal
August 16, 1993 7:00 AM UTC
VRTX acquired exclusive worldwide rights from the Children's Hospital Oakland to develop, manufacture and market compounds for chronic treatment of hemoglobin disorders such as sickle cell anemia and ...